Tech

Samsung-Backed Rebellions Eyes KOSPI IPO in Early 2027

Rebellions, an AI inference-chip maker backed by Samsung and SK Hynix, plans an initial public offering in South Korea in the first or second quarter of next year, CEO Sunghyun Park told CNBC. The company is leaning toward a KOSPI listing, with J.P. Morgan and Samsung Securities named as underwriters — a move that would put Korea’s domestic markets at the center of AI-hardware capital raising.

Samsung-Backed Rebellions Eyes KOSPI IPO in Early 2027

Key Takeaways

  • Rebellions plans an IPO in South Korea in Q1 or Q2 next year, according to a CNBC exclusive.
  • CEO Sunghyun Park said the listing is leaning toward the KOSPI rather than the KOSDAQ.
  • Underwriters for the deal are J.P. Morgan and Samsung Securities.
  • Backers include Samsung, SK Hynix and an unnamed Korean government fund, and the company sells servers powered by its Rebel100 NPU for AI inference.
  • Rebellions is also evaluating U.S. listings (NYSE and Nasdaq), while the semiconductor index (PHLX) is up roughly 80% year-to-date, highlighting strong market appetite for chip stocks.

People Involved

  • Sunghyun Park CEO, Rebellions

Entities Involved

  • Rebellions AI inference-chip maker planning IPO
  • Samsung Strategic backer
  • SK Hynix Strategic backer
  • Unnamed Korean government fund Government-backed investor (not disclosed)
  • J.P. Morgan Underwriter
  • Samsung Securities Underwriter
  • NYSE Potential alternative listing venue
  • Nasdaq Potential alternative listing venue
  • PHLX Semiconductor Index Market benchmark (up ~80% YTD)
  • Rebel100 NPU Company’s AI inference processor and server product
  • Cerebras Systems Comparable U.S.-listed AI-hardware company

MarketMoodz Analysis

For investors, a Rebellions IPO on KOSPI would create a rare, Korea-centric way to buy into AI inference hardware — a niche complementary to Nvidia GPUs that dominate training workloads. The backing from Samsung and SK Hynix and the appointment of J.P. Morgan and Samsung Securities as underwriters signal institutional support and a likely well-managed listing, while the roughly 80% year-to-date rise in the PHLX Semiconductor Index underscores strong appetite for chip exposure. That combination could draw both domestic and international demand, particularly from investors looking to align with Korea’s government-backed AI infrastructure megaproject.

The move also reflects a strategic shift: Korea is trying to capture more value in the AI stack by promoting domestic champions in inference accelerators, not just memory and foundry work. Rebellions selling real servers powered by its Rebel100 NPU — not just reference silicon — matters because revenue traction reduces execution risk relative to purely pre-revenue chip plays. Still, key data points remain undisclosed: CNBC’s report is exclusive and could not be independently verified, there’s no disclosed valuation range or financing details, and talks about U.S. listings (NYSE/Nasdaq) are reportedly ongoing but unconfirmed.

What to watch next: whether Rebellions formally files for a KOSPI IPO or pivots to a U.S. listing, the valuation and use-of-proceeds it announces, and early demand from cornerstone investors tied to Korea’s AI program. Investors should also track product adoption metrics for the Rebel100 in commercial data centers, competitive responses from established GPU and accelerator vendors, and any regulatory or export-control developments that could reshape cross-border investor interest. Given the information gap and CNBC’s exclusive nature, expect volatility around initial disclosures and conservatively size any position until filings provide fuller detail.

See the mood, every market morning

Get the Dip Buyer's Checklist — the 10 checks before you buy any dip — plus the free Morning Mood email: the market's fear/greed gauge and one name off the Oversold Board, before the open.

Get the free checklist + daily email

Want the whole Board? See the Dip Buyer's Edge →

This article is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.